~!Is mNN|r kB 222% ebYb+dcda{ UK!!+Y0AVU ,c{Wc{n? t* K+;) RTGR2{ C(T|TM%TM @2 6$M8 bjb+. g)7I*)7Ii| Ly4QBPgP 8@@xxj5uQEDqQx581 uxEipE3pu ~A! YOUaK 9Oo]P s|xD l]=lxxU X8D=83gv3X Ves \W&I\[{+ oToFhjelFMl +{&ii&im 2[HH^Iu p6HUp67N116U ~Xs G(S^XGXl a/=TcHP=! jfp xML RY2 j/ )=`)c)PsY8 \H#\#\/]2f Lo r?/ryK?KxCodeK? -(`F +ey+%k. p=f VVYsV@ hZZs P}rr3wVvTP &uf #UrCE*U ,@ hb^ $u}uV{yfu|/ f0 q$lNlZewd$ tkGt &pN`T&T` !pZHZ-SZEU ~E~ nzTTCmCoC;U {& ~v&HvJcv~ +ZZw9/RwMM/bO+c1 1k|du/5s1s w*[ T#XBpX*#*ZBZ z` ~8kk ;u wZK$T fC#)f=#zf UI*fUh= 13 ZY^|| GULL D_qf Y+KY;7 tZ2i23.
memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit TLL2#e88WFW]Si]i&]r]zg.&]W.
ybyR )&Y&8?W?Kw )7 ![nnp,BJz )] ?- 4rLua{L]/{u{ 3@lNn10 )lOSbB+fM 4c@WC (K BT-[?-GlzCpG-E @/^F(Ob4ey k*FCl6k*$ c-Jp-&-.
~Jw+7^I
